Quantitative MRI and strength measurements in the assessment of muscle quality in Duchenne muscular dystrophy

Neuromuscular Disorders

Volumn 24, Issue 5, 2014, Pages 409-416

  Wokke, B H ^a   van den Bergen, J C ^a   Versluis, M J ^a   Niks, E H ^a   Milles, J ^a   Webb, A G ^a   van Zwet, E W ^a   Aartsma Rus, A ^a   Verschuuren, J J ^a   Kan, H E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Duchenne muscular dystrophy; Muscle quality; Quantitative MRI

Indexed keywords

FAT; CORTICOSTEROID;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; HAMSTRING; HUMAN; LEG MUSCLE; MALE; MUSCLE ATROPHY; MUSCLE CONTRACTION; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; QUANTITATIVE ANALYSIS; SCHOOL CHILD; TIBIALIS ANTERIOR MUSCLE; TRICEPS SURAE MUSCLE; ADIPOSE TISSUE; HYPERTROPHY; IMAGE PROCESSING; LEG; MUSCULAR DYSTROPHY, DUCHENNE; ORGAN SIZE; PATHOLOGY; PROCEDURES; SKELETAL MUSCLE;

ADIPOSE TISSUE; ADOLESCENT; ADRENAL CORTEX HORMONES; CHILD; HUMANS; HYPERTROPHY; IMAGE PROCESSING, COMPUTER-ASSISTED; LEG; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; ORGAN SIZE; QUADRICEPS MUSCLE;

EID: 84899065426     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2014.01.015     Document Type: Article

References (35)

1. Boland B.J., Silbert P.L., Groover R.V., Wollan P.C., Silverstein M.D. Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy. Pediatr Neurol 1996, 14:7-12.
2. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928.
3. McDouall R.M., Dunn M.J., Dubowitz V. Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy. J Neurol Sci 1990, 99:199-217.
4. Petrof B.J., Shrager J.B., Stedman H.H., Kelly A.M., Sweeney H.L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A 1993, 90:3710-3714.
5. Bowles D.E., McPhee S.W., Li C., et al. Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector. Mol Ther 2012, 20:443-455.
6. Cirak S., Feng L., Anthony K., et al. Restoration of the dystrophin-associated glycoprotein complex after exon skipping therapy in Duchenne muscular dystrophy. Mol Ther 2012, 20:462-467.
7. Goemans N.M., Tulinius M., van den Akker J.T., et al. Systemic administration of PRO051 in Duchenne's muscular dystrophy. N Engl J Med 2011, 364:1513-1522.
8. Malik V., Rodino-Klapac L.R., Viollet L., et al. Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy. Ann Neurol 2010, 67:771-780.
9. Akima H., Lott D., Senesac C., et al. Relationships of thigh muscle contractile and non-contractile tissue with function, strength, and age in boys with Duchenne muscular dystrophy. Neuromuscul Disord 2012, 22:16-25.
10. Arpan I., Forbes S.C., Lott D.J., et al. T(2) mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross-sectional study of lower leg muscles in 5-15-year-old boys with Duchenne muscular dystrophy. NMR Biomed 2013, 26:320-328.
11. Fischmann A., Hafner P., Gloor M., et al. Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy. J Neurol 2013, 260:969-974.
12. Forbes S.C., Walter G.A., Rooney W.D., et al. Skeletal muscles of ambulant children with Duchenne muscular dystrophy: validation of multicenter study of evaluation with MR imaging and MR spectroscopy. Radiology 2013, 269:198-207.
13. Garrood P., Hollingsworth K.G., Eagle M., et al. MR imaging in Duchenne muscular dystrophy: quantification of T1-weighted signal, contrast uptake, and the effects of exercise. J Magn Reson Imaging 2009, 30:1130-1138.
14. Hollingsworth K.G., Garrood P., Eagle M., Bushby K., Straub V. Magnetic resonance imaging in Duchenne muscular dystrophy: longitudinal assessment of natural history over 18 months. Muscle Nerve 2013, 48:586-588.
15. Kim H.K., Laor T., Horn P.S., Racadio J.M., Wong B., Dardzinski B.J. T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. Radiology 2010, 255:899-908.
16. Pichiecchio A., Uggetti C., Egitto M.G., et al. Quantitative MR evaluation of body composition in patients with Duchenne muscular dystrophy. Eur Radiol 2002, 12:2704-2709.
17. Torriani M., Townsend E., Thomas B.J., Bredella M.A., Ghomi R.H., Tseng B.S. Lower leg muscle involvement in Duchenne muscular dystrophy: an MR imaging and spectroscopy study. Skeletal Radiol 2012, 41:437-445.
18. Triplett W.T., Baligand C., Forbes S.C., et al. Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle. Magn Reson Med 2013, 10.1002/mrm.24917.
19. Wren T.A., Bluml S., Tseng-Ong L., Gilsanz V. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR Am J Roentgenol 2008, 190:W8-W12.
20. Kinali M., Arechavala-Gomeza V., Cirak S., et al. Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology 2011, 76:346-353.
21. Liu G.C., Jong Y.J., Chiang C.H., Jaw T.S. Duchenne muscular dystrophy: MR grading system with functional correlation. Radiology 1993, 186:475-480.
22. Gaeta M., Scribano E., Mileto A., et al. Muscle fat fraction in neuromuscular disorders: dual-echo dual-flip-angle spoiled gradient-recalled MR imaging technique for quantification - a feasibility study. Radiology 2011, 259:487-494.
23. Marden F.A., Connolly A.M., Siegel M.J., Rubin D.A. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skeletal Radiol 2005, 34:140-148.
24. Mercuri E., Jungbluth H., Muntoni F. Muscle imaging in clinical practice. Diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders. Curr Opin Neurol 2005, 18:526-537.
25. Dixon W.T. Simple proton spectroscopic imaging. Radiology 1984, 153:189-194.
26. Kovanlikaya A., Guclu C., Desai C., Becerra R., Gilsanz V. Fat quantification using three-point dixon technique: in vitro validation. Acad Radiol 2005, 12:636-639.
27. Wokke B.H., Bos C., Reijnierse M., et al. Comparison of dixon and T1-weighted MR methods to assess the degree of fat infiltration in duchenne muscular dystrophy patients. J Magn Reson Imaging 2013, 38:619-624.
28. * estimation with multifrequency fat spectrum modeling. Magn Reson Imaging 2008, 60:1122-1134.
29. * estimation. J Magn Reson Imaging 2007, 26:1153-1161.
30. Kan H.E., Scheenen T.W., Wohlgemuth M., et al. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 2009, 19:357-362.
31. Mathur S., Lott D.J., Senesac C., et al. Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil 2010, 91:1051-1058.
32. Hogrel J.Y., Payan C.A., Ollivier G., et al. Development of a French isometric strength normative database for adults using quantitative muscle testing. Arch Phys Med Rehabil 2007, 88:1289-1297.
33. Cros D., Harnden P., Pellissier J.F., Serratrice G. Muscle hypertrophy in Duchenne muscular dystrophy. A pathological and morphometric study. J Neurol 1989, 236:43-47.
34. Chan S., Head S.I., Morley J.W. Branched fibers in dystrophic mdx muscle are associated with a loss of force following lengthening contractions. Am J Physiol Cell Physiol 2007, 293:C985-C992.
35. Coulton G.R., Curtin N.A., Morgan J.E., Partridge T.A. The mdx mouse skeletal muscle myopathy: II. Contractile properties. Neuropathol Appl Neurobiol 1988, 14:299-314.